Desjardins Raises Earnings Estimates for Great-West Lifeco

Key Points

• Desjardins has raised its Q3 2025 earnings per share (EPS) estimate for Great-West Lifeco from $1.21 to $1.23, while maintaining a "Hold" rating and a price target of $60.00.
• Other analysts, like TD Securities and Barclays, have also increased their price targets for the stock, indicating growing optimism among equities analysts.
• Great-West Lifeco recently paid a quarterly dividend of $0.61 per share, translating to an annualized amount of $2.44 and a dividend yield of 4.2%.

Great-West Lifeco Inc. (TSE:GWO - Free Report) - Equities research analysts at Desjardins upped their Q3 2025 earnings per share (EPS) estimates for Great-West Lifeco in a report released on Tuesday, October 14th. Desjardins analyst D. Young now forecasts that the company will post earnings of $1.23 per share for the quarter, up from their prior forecast of $1.21. Desjardins has a "Hold" rating and a $60.00 price objective on the stock. The consensus estimate for Great-West Lifeco's current full-year earnings is $4.45 per share. Desjardins also issued estimates for Great-West Lifeco's FY2025 earnings at $4.85 EPS, FY2026 earnings at $5.25 EPS and FY2027 earnings at $5.65 EPS.

A number of other equities analysts also recently weighed in on GWO. TD Securities boosted their price target on Great-West Lifeco from C$59.00 to C$66.00 in a research report on Wednesday, October 8th. Barclays boosted their price target on Great-West Lifeco from C$57.00 to C$58.00 and gave the stock an "overweight" rating in a research report on Wednesday, October 8th. BMO Capital Markets boosted their price target on Great-West Lifeco from C$55.00 to C$56.00 and gave the stock a "market perform" rating in a research report on Thursday, August 7th. Finally, Scotiabank boosted their price target on Great-West Lifeco from C$59.00 to C$61.00 and gave the stock an "outperform" rating in a research report on Thursday, August 7th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and five have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of C$57.78.

Great-West Lifeco Stock Down 0.9%

Shares of TSE GWO opened at C$58.20 on Thursday. The business's 50 day moving average price is C$55.08 and its two-hundred day moving average price is C$53.11. The company has a market cap of C$54.21 billion, a PE ratio of 14.59, a price-to-earnings-growth ratio of 2.26 and a beta of 0.65. Great-West Lifeco has a twelve month low of C$44.89 and a twelve month high of C$59.36.

Great-West Lifeco Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, September 29th. Stockholders of record on Monday, September 29th were issued a dividend of $0.61 per share. This represents a $2.44 dividend on an annualized basis and a dividend yield of 4.2%. The ex-dividend date was Friday, August 29th. Great-West Lifeco's payout ratio is currently 58.40%.

Great-West Lifeco announced that its Board of Directors has initiated a share repurchase program on Tuesday, August 5th that permits the company to buyback $0.00 in shares. This buyback authorization permits the company to buy shares of its stock through open market purchases. Stock buyback programs are typically an indication that the company's leadership believes its stock is undervalued.

About Great-West Lifeco

Great-West Lifeco is one of the three big Canadian life insurance firms. With just under half of the firm's profit and revenue in Canada, Great-West also operates in the U.S. and Europe. In Canada, Great-West provides both individual and group insurance. In the United States, Great-West operates Putnam Investments and defined-contribution recordkeeping firm Empower Retirement.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.